Contact Us

[New Product] Beilu Pharma's Bimatoprost Ophthalmic Solution Approved by NMPA

2026/09/20


Recently, Beilu Pharma received the Drug Registration Certificate for Bimatoprost Ophthalmic Solution, approved and issued by the National Medical Products Administration (NMPA).

The originator of Bimatoprost Ophthalmic Solution is Allergan Inc. (USA). The product is indicated for the reduction of  intraocular pressure (IOP) in patients with open-angle glaucoma andocular hypertension.



References
Related Products
Related Beilu News